SOL- Solihull Specialist Smoking Cessation Service 2024

Award

Value

£0

Suppliers

Classifications

  • Miscellaneous health services

Tags

  • award

Submission Deadline

1 year ago

Published

1 year ago

Description

Solihull MBC is seeking to procure a Specialist Stop Smoking Service. This tender opportunity falls under The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR). Solihull recognises the value of providing a local specialist smoking cessation service, and the Specification sets out the requirements for a new community based Public Health Service. The aim of the Service is to improve service provision for best value, realise innovative solutions to reach target communities through best practice approaches and wider system collaboration. The Service will play a pivotal role in supporting delivery of the national Smoke Free 2030 objective, through reducing Solihull's smoking prevalence rates year on year, to achieve a 5% or less prevalence rate across all community cohorts. The current smoking prevalence rate for the borough is 10.6%, although this is above the England average, we have above average rates for specific community groups. The new Service being sought will be partially funded through new investment from Office for Health Improvement and Disparities (OHID), and therefore will be required to have both the capability and capacity to work in accordance with grant OHID conditions. Please refer to '08 Schedule 1 Specification SOL-18741 vFinal' for further details.The initial term of the Contract will be for the period of five years from commencement but may be extended by mutual agreement by any increment of up to two further years to an expiry date no later than 31st August 2031. Any modifications to the contract will be in accordance PSR Regulations 2023.There is a maximum budget for year 1 of £322,250.00. The tender will be evaluated against Quality, Price , and Social Value criteria, and a minimum financial turnover threshold applies. Please refer to the tender documents for further information.

Additional information: This tender opportunity falls under The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR).

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete